NEXGEL, Inc. (NXGL): Company Short-Term Debts

Public company logo of NEXGEL Inc (NXGL)

The growth of B2B contracts and e-commerce channels is driving the development of NEXGEL, Inc. (NXGL). The short-term debt time series demonstrates the current parameter 0.00, which correlates with business scaling. Proprietary electronic cross-linking of materials enhances drug delivery efficiency. Stable clinical supplies of hydrogel products ensure a predictable cash flow, eliminating the risk of product obsolescence.

NXGL (NEXGEL) Company Short-Term Debts history from 07/04/2022 to 10/29/2026

Analytical breakdowns for NEXGEL Inc (NXGL)

- stock price and consensus target price:
Stock Price NEXGEL|NXGL - Analyst Median Target
- stock exchange capitalization data:
Market Capitalization NEXGEL, Inc.|NXGL - Real Price to Acquire Entire Company
- business book valuation details:
Book Value per Share NEXGEL|NXGL - Book Capitalization|Market Value to Book Value Ratio nexgel.com|NXGL - Aggregate Company Assets
- debt and liquidity data:
Total Debt to Equity Ratio NEXGEL, Inc.|NXGL - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital NEXGEL, Inc.|NXGL - Company Total Debt Obligations|Debt to Book Capitalization Ratio NEXGEL, Inc.|NXGL - Company Long-Term Indebtedness|Company Short-Term Debt NEXGEL|Quick Liquidity Indicator nexgel.com
- net income and valuation multiples indicators:
NXGL - Profit After Payment of Taxes
Fundamental company analysis:NXGL - NEXGEL
Flagship merchandise of NEXGEL Inc

Analyzing the short-term debt dynamics of NEXGEL, Inc. (NXGL) allows for an assessment of the efficiency of managing operating expenses related to production and logistics outsourcing. This indicator aggregates all liabilities with a maturity of up to one year, measuring current liquidity and the risk of cash flow gaps. An increase in this metric signals borrowing to support current processes, while a decrease reflects the optimization of the debt load.

Direct competitors

Intuitive - Company Short-Term Debts|Short-Term Debt Volume Danaher Corporation DHR|BDX: Company Short-Term Debts|Company Current Liabilities STERIS Group|WST (West Pharmaceutical Services) - Company Short-Term Debts|Company Short-Term Debts baxter.com|Company Short-Term Debt Masimo (MASI)|Company Short-Term Debt STVN (Stevanato Group SpA)|Teleflex Inc - Company Current Liabilities|Company Short-Term Loans and Borrowings MMSI|Envista Holdings - Company Short-Term Debts|Short-Term Debt Volume icumed.com ICUI|Dentsply Sirona (XRAY) - Company Short-Term Debt|Company Short-Term Indebtedness LMAT|Company Short-Term Debt AtriCure Corp|STAAR Surgical Co (STAA) - Short-Term Debt Volume|Company Current Liabilities NAGE (ChromaDex)|Amount of Current Liabilities ZIMV|Company Short-Term Debt AngioDynamics ANGO|Company Short-Term Loans and Borrowings CERS|TKNO: Company Current Liabilities|MGRM - Company Short-Term Debts|sharpstechnology.com (STSS) - Company Short-Term Debt|Company Current Liabilities InfuSystem Holdings, Inc.|UTMD (Utah Medical Products, Inc.) - Company Short-Term Debts|Short-Term Debt KORU Medical Systems Inc. KRMD|Company Short-Term Debt Nyxoah, S.A. (NYXH)|Microbot Medical, Inc - Company Short-Term Indebtedness|Pro-Dex, Inc. - Company Current Liabilities|Amount of Current Liabilities ZTEK (zentek.com)|ELUT - Company Short-Term Debt|Short-Term Debt Volume Milestone Scientific Inc MLSS|retractable.com (RVP) - Company Short-Term Debt|Company Short-Term Indebtedness HBIO|FEMY (Femasys Inc.) - Company Short-Term Debts|Short-Term Debt Meihua Medical MHUA|Company Current Liabilities POAI (Predictive Oncology)|callanjmb.com - Company Short-Term Indebtedness|Company Short-Term Debts ATRI (Atrion Corp)|Short-Term Indebtedness NeuroMetrix Corporation